[Development and validation of novel clinical endpoints in intermediate age-related macular degeneration in MACUSTAR].
Terheyden JH, Finger RP, Schmitz-Valckenberg S, Agostini H, Dahlke C, Kuehlewein L, Lang GE, Pauleikhoff D, Wolf A, Boettger MK, Luhmann UFO, Asmus F, Holz FG; MACUSTAR-Konsortium.
Terheyden JH, et al.
Ophthalmologe. 2019 Dec;116(12):1186-1193. doi: 10.1007/s00347-019-0907-1.
Ophthalmologe. 2019.
PMID: 31087116
Review.
German.